The Zacks Analyst Blog Highlights: Pfizer, Eli Lilly, Archer Daniels Midland, RadioShack and Sprint - Press Releases
February 01 2012 - 3:30AM
Zacks
For Immediate Release
Chicago, IL – February 1, 2012 – Zacks.com announces the list of
stocks featured in the Analyst Blog. Every day the Zacks Equity
Research analysts discuss the latest news and events impacting
stocks and the financial markets. Stocks recently featured in the
blog include Pfizer ( PFE),
Eli Lilly ( LLY), Archer Daniels
Midland ( ADM), RadioShack ( RSH) and
Sprint ( S).
Get the most recent insight from Zacks Equity Research with the
free Profit from the Pros newsletter:
http://at.zacks.com/?id=5513
Here are highlights from Tuesday’s Analyst
Blog:
Earnings Roll Out, EU Makes
Progress
There is favorable looking news out of Europe this morning, with
Greece appearing to be making progress in arm-twisting its private
creditors to accept ‘voluntary’ losses on their holdings and all
except two of the 27 European Union members agreeing to put more
flesh on their plans to move towards a closer fiscal union.
As a follow up to the December agreement, 25 out of the 27 EU
members agreed to new rules that define new deficit and debt levels
for member countries and provides for stricter enforcement
mechanisms. The two hold-outs -- Britain and the Czech Republic --
are not part of the Euro-zone, which is a sub-set of the broader
EU.
The agreement requires governments to keep budget deficits at an
average of 0.5% of GDP over the economic cycle and to reduce
government debt to 60% of GDP over time. There will be fines for
errant governments, with the European Court of Justice given the
authority to impose fines, which will be capped at 0.5% of GDP.
The leaders did not announce the creation of a €500 billion
permanent bailout fund, known as the European Stability Mechanism.
A decision on that issue, including the proposal to boost the size
of the fund, has been put off till the next EU summit on March 1.
This is an incremental positive development for Europe as it moves
the union towards greater fiscal integration.
On the earnings front, Pfizer ( PFE) came ahead
of earnings and revenue expectations, but the company lowered its
2012 earnings guidance. Eli Lilly ( LLY) also came
ahead of expectations. Both drug giants recent lost patent
protection on core blockbuster drugs, with Pfizer’s Lipitor and
Lilly’s Zyprexa going generic. Archer Daniels
Midland ( ADM) missed earnings expectations on continued
margin pressures in its oilseeds business, offsetting its
better-than-expected revenue numbers.
RadioShack ( RSH) pre-announced weaker than
expected numbers for the quarter, citing softness in its business
reselling Sprint ( S) wireless service and margin
pressures due to greater reliance on promotions during the holiday
season.
Want more from Zacks Equity Research? Subscribe to the free
Profit from the Pros newsletter: http://at.zacks.com/?id=5515.
About Zacks Equity Research
Zacks Equity Research provides the best of quantitative and
qualitative analysis to help investors know what stocks to buy and
which to sell for the long-term.
Continuous coverage is provided for a universe of 1,150 publicly
traded stocks. Our analysts are organized by industry which gives
them keen insights to developments that affect company profits and
stock performance. Recommendations and target prices are six-month
time horizons.
Zacks "Profit from the Pros" e-mail newsletter provides
highlights of the latest analysis from Zacks Equity Research.
Subscribe to this free newsletter today:
http://at.zacks.com/?id=5517
About Zacks
Zacks.com is a property of Zacks Investment Research, Inc.,
which was formed in 1978 by Leon Zacks. As a PhD from MIT Len knew
he could find patterns in stock market data that would lead to
superior investment results. Amongst his many accomplishments was
the formation of his proprietary stock picking system; the Zacks
Rank, which continues to outperform the market by nearly a 3 to 1
margin. The best way to unlock the profitable stock recommendations
and market insights of Zacks Investment Research is through our
free daily email newsletter; Profit from the Pros. In short, it's
your steady flow of Profitable ideas GUARANTEED to be worth your
time! Register for your free subscription to Profit from the Pros
at http://at.zacks.com/?id=5518.
Visit http://www.zacks.com/performance for information about the
performance numbers displayed in this press release.
Follow us on Twitter: http://twitter.com/zacksresearch
Join us on Facebook:
http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts
Disclaimer: Past performance does not guarantee future results.
Investors should always research companies and securities before
making any investments. Nothing herein should be construed as an
offer or solicitation to buy or sell any security.
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
http://www.zacks.com
ARCHER DANIELS (ADM): Free Stock Analysis Report
LILLY ELI & CO (LLY): Free Stock Analysis Report
PFIZER INC (PFE): Free Stock Analysis Report
RADIOSHACK CORP (RSH): Free Stock Analysis Report
SPRINT NEXTEL (S): Free Stock Analysis Report
To read this article on Zacks.com click here.
Archer Daniels Midland (NYSE:ADM)
Historical Stock Chart
From May 2024 to Jun 2024
Archer Daniels Midland (NYSE:ADM)
Historical Stock Chart
From Jun 2023 to Jun 2024